Summary
Latest filing:
Edward J. Brennan is Chief Scientific Officer of Medicus Pharma Ltd. (MDCX). 4 SEC Form 4 filings on record going back to 2025, most recently on 8 September 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Edward J. Brennan has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Edward J. Brennan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- August J. Troendle - $247.96M of MEDP open-market activity in the last 12 months
- A/S Genmab - $234.86M of MRUS open-market activity in the last 12 months
- Weiss Asset Management LP - $233.35M of AVDL open-market activity in the last 12 months
- James Edgemond - $201.52M of UTHR open-market activity in the last 12 months
- Scilex Holding Co - $200.00M of SMNR open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M of TYRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Edward J. Brennan?
Edward J. Brennan is a corporate insider, tracked as Chief Scientific Officer of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Edward J. Brennan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Edward J. Brennan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Edward J. Brennan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
